drugset / Trial / NCT04837703

Managed Access Programs for ETB115, Eltrombopag

NCT04837703 ↗

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to ETB115, Eltrombopag

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Eltrombopag Small molecule — —

Indications